Clinical trial Talapro-3
Talapro-3: A Phase 3, Randomized, Double-Blind, Study Of Talazoparib With Enzalutamide Versus Placebo With Enzalutamide In Men With Ddr Gene Mutated Metastatic Castration-Sensitive Prostate Cancer
| Cancers | |
|---|---|
| Organ | prostate |
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Pfizer |
| EudraCT Identifier | 2021-000248-23 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04821622 |
| Last update |